Search

everythinglearnresearchcommunity

for

Search:↓

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Natural products can help overcome cancer drug resistance.

Cepharanthine can potentially treat gastric cancer by stopping tumor growth.

Onions may help reduce cancer risk and obesity-related issues.

Physical activity, height, and smoking affect prostate cancer risk.

A group has developed therapies that show promise for treating cancer and various other conditions.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Runx1 controls fat-related genes important for normal and cancer cell growth, affecting skin and hair cell behavior.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.